Ameritas Investment Partners’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3K | Buy |
2,455
+1,118
| +84% | +$12.5K | ﹤0.01% | 2519 |
|
|
2025
Q1 | $16.4K | Hold |
1,337
| – | – | ﹤0.01% | 2637 |
|
|
2024
Q4 | $15K | Hold |
1,337
| – | – | ﹤0.01% | 2755 |
|
|
2024
Q3 | $9.32K | Hold |
1,337
| – | – | ﹤0.01% | 2943 |
|
|
2024
Q2 | $10.1K | Buy |
+1,337
| New | +$10.1K | ﹤0.01% | 2926 |
|
|
2022
Q2 | – | Sell |
-546
| Closed | -$4K | – | 3180 |
|
|
2022
Q1 | $4K | Hold |
546
| – | – | ﹤0.01% | 3000 |
|
|
2021
Q4 | $6K | Hold |
546
| – | – | ﹤0.01% | 3017 |
|
|
2021
Q3 | $9K | Hold |
546
| – | – | ﹤0.01% | 2967 |
|
|
2021
Q2 | $13K | Buy |
+546
| New | +$13K | ﹤0.01% | 2892 |
|